Surgical treatment for large hepatocellular carcinoma: Does size matter?

ANZ Journal of Surgery

Volumn 82, Issue 7-8, 2012, Pages 510-517

  Tsoulfas, Georgios ^a   Mekras, Alexandros ^a   Agorastou, Polyxeni ^a   Kiskinis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Disease free survival; Large hepatocellular carcinoma (HCC); Liver resection; Liver transplantation; Recurrence; Surgical treatment

Indexed keywords

HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; PATHOLOGY; REVIEW; RISK FACTOR; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; RISK FACTORS; TUMOR BURDEN;

EID: 84864753572     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2012.06079.x     Document Type: Review

References (87)

1. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
2. Parkin DM, Whelan SL, Ferlay J etal. Cancer Incidence in Five Continents. IARC Science Publications, Vol. 143. Lyon, France: IARC, 1997.
3. Amin J, Dore GJ, O'Connell DL etal. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J. Hepatol. 2006; 45: 197-203.
4. Taura N, Yatsuhashi H, Hamasaki K etal. Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: long term trends in Japan. Hepatol. Res. 2006; 34: 130-4.
5. Monnet E, Collin-Naudet E, Bresson-Hadni S etal. Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study. J. Hepatol. 2006; 44: 499-506.
6. Pawlik TM, Poon RT, Abdalla EK etal. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch. Surg. 2005; 140: 450-7.
7. Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
8. Ou LH, Chau GY, Tsay SH etal. Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients. Zhonghua Yi Xue Za Zhi (Taipei) 1997; 60: 40-7.
9. Lee NH, Chau GY, Lui WY, King KL, Tsay SH, Wu CW. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10cm in diameter. Br. J. Surg. 1998; 85: 1654-7.
10. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg. 1991; 214: 114-7.
11. Lai EC, Ng IO, Ng MM etal. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990; 11: 815-8.
12. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J. Surg. Oncol. 2000; 73: 109-14.
13. Aguayo A, Pat YZ. Nonsurgical treatment of hepatocellular carcinoma. Semin. Oncol. 2001; 28: 503-13.
14. Curley SA, Izzo F, Ellis LM, Vauthey JN, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 2000; 232: 381-91.
15. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann. Surg. 1999; 229: 790-9.
16. Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann. Surg. 2009; 249: 118-23.
17. Shah SA, Wei AC, Cleary SP etal. Prognosis and results after resection of very large (>or=10cm) hepatocellular carcinoma. J. Gastrointest. Surg. 2007; 11: 589-95.
18. Miyoshi A, Takahashi T, Otsuka T, Kohya N, Miyazaki K. Efficacy of major hepatectomy for large hepatocellular carcinoma. Hepatogastroenterology 2009; 56: 91-2.
19. Hanazaki K, Kajikawa S, Shimozawa N etal. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10cm. Hepatogastroenterology 2002; 49: 518-23.
20. Liau KH, Ruo L, Shia J etal. Outcome of partial hepatectomy for large (>10cm) hepatocellular carcinoma. Cancer 2005; 104: 1948-55.
21. Cho YB, Lee KU, Lee HW etal. Outcomes of hepatic resection for a single large hepatocellular carcinoma. World J. Surg. 2007; 31: 795-801.
22. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter. J. Am. Coll. Surg. 2002; 194: 592-602.
23. Ramacciato G, Mercantini P, Petrucciani N etal. Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma? Am. Surg. 2010; 76: 1189-97.
24. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br. J. Surg. 2007; 94: 320-6.
25. Shimada K, Sakamoto Y, Esaki M, Kosuge T. Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10cm or larger in diameter. Langenbecks Arch. Surg. 2008; 393: 521-6.
26. Nagano Y, Tanaka K, Togo S etal. Efficacy of hepatic resection for hepatocellular carcinomas larger than 10cm. World J. Surg. 2005; 29: 66-71.
27. Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch. Surg. 2005; 390: 259-65.
28. Ng KM, Yan TD, Black D, Chu FC, Morris DL. Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford) 2009; 11: 311-20.
29. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10cm or more) after surgical resection. Ann. Surg. Oncol. 2007; 14: 2817-23.
30. Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10cm: two decades of experience at Chang Gung memorial hospital. Ann. Surg. Oncol. 2003; 10: 1070-6.
31. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig. Surg. 2004; 21: 380-6.
32. Furuta T, Sonoda T, Matsumata T, Kanematsu T, Sugimachi K. Hepatic resection for a hepatocellular carcinoma larger than 10cm. J. Surg. Oncol. 1992; 51: 114-7.
33. Mok KT, Wang BW, Lo GH etal. Multimodality management of hepatocellular carcinoma larger than 10cm. J. Am. Coll. Surg. 2003; 197: 730-8.
34. Zhou XD, Tang ZY, Ma ZC etal. Surgery for large primary liver cancer more than 10cm in diameter. J. Cancer Res. Clin. Oncol. 2003; 129: 543-8.
35. Xu L, Huang L. Li BK, Zhang YQ, Li JQ, Yuan YF. Clinicopathological features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig. Surg. 2008; 25: 376-82.
36. Tsai TJ, Chau GY, Lui WY etal. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-8.
37. Kosuge T, Makuuchi M, Takayama T, Yamamoto JK, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993; 40: 328-32.
38. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery 1997; 122: 571-7.
39. Marelli L, Grasso A, Pleguezuelo M etal. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann. Surg. Oncol. 2008; 15: 3503-11.
40. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann. Surg. 2007; 245: 435-42.
41. Grazi GL, Ercolani G, Pierangeli F etal. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann. Surg. 2001; 234: 71-8.
42. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751-5.
43. Yachnin S, Soltani K, Lester EP. Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha fetoprotein. J. Allergy Clin. Immunol. 1980; 65: 127-35.
44. Iwatsuki S, Dvorchik I, Marsh JW etal. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J. Am. Coll. Surg. 2000; 191: 389-94.
45. Peck AB, Murgita RA, Wigzell H. Cellular and genetic restrictions in the immunoregulatory activities of a-fetoprotein. II. A-fetoprotein-induced suppression of cytotoxic T lymphocyte development. J. Exp. Med. 1978; 148: 360-72.
46. Murgita RA, Tomasi TB. Suppression of the immune response by a-fetoprotein on the primary and secondary antibody response. J. Exp. Med. 1975; 141: 269-86.
47. Alisa A, Boswell S, Pathan AA, Ayaru L, Williams R, Behboudi S. Human CD4 T cells recognize an epitope within a-fetoprotein sequence and develop into TGF-β-producing CD4 T cell. J. Immunol. 2008; 180: 5109-17.
48. Um SH, Mulhall C, Alisa A etal. a-fetoprotein impairs APC function and induces their apoptosis. J. Immunol. 2004; 173: 1772-8.
49. Yamamoto M, Tatsumi T, Miyagi T etal. a-fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells. Clin. Exp. Immunol. 2011; 165: 211-9.
50. Shuto T, Hirohashi K, Kubo S etal. Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 413-6.
51. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL. Anterior approach for difficult major right hepatectomy. World J. Surg. 1996; 20: 314-7.
52. Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann. Surg. 2006; 244: 194-203.
53. Liu CL, Fan ST, Lo CM, Poon RT, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann. Surg. 2000; 232: 25-31.
54. Kubota K, Makuuchi M, Kusaka K etal. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-81.
55. Vauthey JN, Chaoui A, Do KA etal. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-9.
56. Sugawara Y, Yamamoto J, Higashi H etal. Preoperative portal embolization in patients with hepatocellular carcinoma. World J. Surg. 2002; 26: 105-10.
57. Farges O, Belghiti J, Kianmanesh R etal. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg. 2003; 237: 208-17.
58. Varela M, Sanchez W, Bruix J, Gores GJ. Hepatocellular carcinoma in the setting of liver transplantation. Liver Transpl. 2006; 12: 1028-36.
59. Kobayashi A, Takahashi S, Ishii H etal. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization. Eur. J. Surg. Oncol. 2007; 33: 1019-24.
60. Inoue K, Nakamura T, Kinoshita T etal. Volume reduction surgery for advanced hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2004; 130: 362-6.
61. Hong K, Georgiades CS, Geschwind JF. Technology insight: image-guided therapies for hepatocellular carcinoma - intra-arterial and ablative techniques. Nat. Clin. Pract. Oncol. 2006; 3: 315-24.
62. Takayasu K, Arii S, Ikai I etal. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-9.
63. Xu HX, Lu MD, Xie XY etal. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin. Radiol. 2005; 60: 1018-25.
64. Heckman JT, Devera MB, Marsh JW etal. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann. Surg. Oncol. 2008; 15: 3169-77.
65. Otto G, Herber S, Heise M etal. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl. 2006; 12: 1260-7.
66. Zhou XD, Tang ZY, Yu YQ etal. Prognostic factors of primary liver cancer: report of 83 patients surviving 5 years or more compared with 811 patients surviving less than 5 years. J. Exp. Clin. Cancer Res. 1991; 10: 81-6.
67. Pawlik TM, Poon RT, Abdalla EK etal. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005; 137: 403-10.
68. Zhou XD, Yu YQ, Tang ZY etal. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology 1993; 40: 333-6.
69. Kobayashi A, Pulitano C. Treatment of huge HCC: extending the indications for liver resection. Ann. Surg. Oncol. 2007; 15: 1549.
70. Roayaie S, Frischer JS, Emre SH etal. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann. Surg. 2002; 235: 533-9.
71. Mazzaferro V, Regalia E, Doci R etal. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996; 334: 693-9.
72. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am. J. Transplant. 2007; 7: 2587-96.
73. Duffy JP, Vardanian A, Benjamin E etal. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann. Surg. 2007; 246: 502-9.
74. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl. 2007; 13: 391-9.
75. Koschny R, Schmidt J, Ganten TM. Beyond Milan criteria - chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin. Transplant. 2009; 23: 49-60.
76. Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol. 2007; 3: 429-39.
77. Hwang S, Moon DB, Lee SG. Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl. Int. 2010; 23: 723-7.
78. Marelli L, Grasso A, Pleguezuelo M etal. Tumor size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann. Surg. Oncol. 2008; 15: 3503-11.
79. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann. Surg. 2004; 240: 451-9.
80. Takada Y, Ueda M, Ito T etal. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl. 2006; 12: 912-9.
81. Mazzaferro V, Chun YS, Poon RT etal. Liver transplantation for hepatocellular carcinoma. Ann. Surg. Oncol. 2008; 15: 1001-7.
82. Ito T, Takada Y, Ueda M etal. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007; 13: 1637-44.
83. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig. Dis. 2007; 25: 310-2.
84. Belghiti J. Resection and liver transplantation for HCC. J. Gastroenterol. 2009; 44: 132-5.
85. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur. J. Surg. Oncol. 2011; 37: 521-5.
86. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur. J. Cancer 2007; 43: 979-92.
87. Sato F, Hatano E, Kitamura K etal. MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within Milan criteria. PLoS ONE 2011; 6: e16435.